Christopher C Capelli, M.D., is currently the Vice President, Technology Based Ventures at The University of Texas M. D. Anderson Cancer Center (UTMDACC) where he plays the leading role in enabling the commercialization of products and services at M.D. Anderson. Dr. Capelli has direct oversight of the Office of Technology Commercialization. Prior to coming to UTMDACC, Dr. Capelli was the Director of the Office of Technology Management (OTM) at the University of Pittsburgh. A graduate of Massachusetts Institute of Technology (MIT) with a Bachelor of Science degree in Mechanical Engineering, Dr. Capelli earned his MD from the University of Wisconsin Medical School and maintains a medical license in the State of Wisconsin. As a result of his scientific work since graduating from MIT, Dr. Capelli holds over two dozen patents and patent applications worldwide. As a businessman, Dr. Capelli has been directly involved in the start-up of numerous venture-capital backed biomedical company ventures.